02 December 2024
SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics
UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million
SOLASTA Bio raises $14m for peptide-based biopesticides: SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for syntheticsMore articles
02 December 2024
SOLASTA Bio completes $14m Series A to accelerate nature-inspired crop protection
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round to accelerate the development of its ...
02 December 2024
SOLASTA Bio completes US$14mn Series A funding round
“SOLASTA Bio has come a long way since we set out on this journey three years ago. Having established operations in the UK and US, we’ve now got an international ...